Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 S Fournel, M Aguerre-Girr, X Huc, F Lenfant, A Alam, A Toubert, ... The journal of immunology 164 (12), 6100-6104, 2000 | 595 | 2000 |
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells A Nassif, A Bensussan, L Boumsell, A Deniaud, H Moslehi, P Wolkenstein, ... Journal of allergy and clinical immunology 114 (5), 1209-1215, 2004 | 522 | 2004 |
Blocking antibodies targeting the CD39/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies I Perrot, HA Michaud, M Giraudon-Paoli, S Augier, A Docquier, L Gros, ... Cell reports 27 (8), 2411-2425. e9, 2019 | 398 | 2019 |
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis A Nassif, A Bensussan, N Bachot, M Bagot, L Boumsell, JC Roujeau, ... Journal of Investigative Dermatology 118 (4), 728-733, 2002 | 387 | 2002 |
Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. KT Hall, L Boumsell, JL Schultze, VA Boussiotis, DM Dorfman, ... Proceedings of the National Academy of Sciences 93 (21), 11780-11785, 1996 | 353 | 1996 |
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large … T Hercend, JD Griffin, A Bensussan, RE Schmidt, MA Edson, A Brennan, ... The Journal of clinical investigation 75 (3), 932-943, 1985 | 326 | 1985 |
IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro JD Bouaziz, S Calbo, M Maho‐Vaillant, A Saussine, M Bagot, ... European journal of immunology 40 (10), 2686-2691, 2010 | 315 | 2010 |
The human T-cell receptor O Acuto, M Fabbi, A Bensussan, C Milanese, TJ Campen, HD Royer, ... Journal of clinical immunology 5, 141-157, 1985 | 264 | 1985 |
Evaluation of the potential role of cytokines in toxic epidermal necrolysis A Nassif, H Moslehi, S Le Gouvello, M Bagot, L Lyonnet, L Michel, ... Journal of Investigative Dermatology 123 (5), 850-855, 2004 | 257 | 2004 |
ENTPD1/CD39 is a promising therapeutic target in oncology J Bastid, A Cottalorda-Regairaz, G Alberici, N Bonnefoy, JF Eliaou, ... Oncogene 32 (14), 1743-1751, 2013 | 248 | 2013 |
IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model D Zagury, H Le Buanec, A Mathian, P Larcier, R Burnett, Z Amoura, ... Proceedings of the National Academy of Sciences 106 (13), 5294-5299, 2009 | 245 | 2009 |
Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity J Bastid, A Regairaz, N Bonnefoy, C Déjou, J Giustiniani, C Laheurte, ... Cancer immunology research 3 (3), 254-265, 2015 | 243 | 2015 |
Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells P Fons, S Chabot, JE Cartwright, F Lenfant, F L'Faqihi, J Giustiniani, ... Blood 108 (8), 2608-2615, 2006 | 240 | 2006 |
CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas [see comments] JF Emile, ML Boulland, C Haioun, P Kanavaros, T Petrella, ... | 235 | 1996 |
Activation of human thymocytes via the 50KD T11 sheep erythrocyte binding protein induces the expression of interleukin 2 receptors on both T3+ and T3-populations. DA Fox, RE Hussey, KA Fitzgerald, A Bensussan, JF Daley, ... Journal of immunology (Baltimore, Md.: 1950) 134 (1), 330-335, 1985 | 229 | 1985 |
CD molecules 2006—human cell differentiation molecules H Zola, B Swart, A Banham, S Barry, A Beare, A Bensussan, L Boumsell, ... Journal of immunological methods 319 (1-2), 1-5, 2007 | 224 | 2007 |
Human decidual NK cells: unique phenotype and functional properties–a review J Tabiasco, M Rabot, M Aguerre-Girr, H El Costa, A Berrebi, O Parant, ... Placenta 27, 34-39, 2006 | 224 | 2006 |
Biological activity of soluble CD100. II. Soluble CD100, similarly to H-SemaIII, inhibits immune cell migration S Delaire, C Billard, R Tordjman, A Chédotal, A Elhabazi, A Bensussan, ... The Journal of Immunology 166 (7), 4348-4354, 2001 | 224 | 2001 |
CD39/adenosine pathway is involved in AIDS progression M Nikolova, M Carriere, MA Jenabian, S Limou, M Younas, A Kök, S Huë, ... PLoS pathogens 7 (7), e1002110, 2011 | 212 | 2011 |
CD molecules 2005: human cell differentiation molecules H Zola, B Swart, I Nicholson, B Aasted, A Bensussan, L Boumsell, ... Blood 106 (9), 3123-3126, 2005 | 210 | 2005 |